NAD+ and Cellular Energy: The Coenzyme Revolution in Aging Research
Discover the science behind NAD+ (Nicotinamide Adenine Dinucleotide) and its critical role in cellular metabolism, DNA repair, and longevity research pathways.
10 min readRead
Back to Research GuideResearch Compounds
IGF-1 LR3: Long-Acting Growth Factor Research
Dr. James Mitchell, Ph.D.February 2, 202610 min read
IGF-1Growth FactorCell CultureAnabolicMetabolism
Understanding IGF-1 LR3, a modified insulin-like growth factor with enhanced potency and duration for advanced cellular and metabolic research.
IGF-1 LR3 (Long R3 IGF-1) is a modified form of human insulin-like growth factor-1 with enhanced biological activity and an extended half-life. This 83-amino acid analog has become an essential tool in cell biology, metabolic research, and tissue engineering studies where prolonged IGF-1 receptor activation is desired.
IGF-1 Biology
Native IGF-1 (Insulin-like Growth Factor 1) is a 70-amino acid polypeptide structurally similar to insulin. It mediates many of the anabolic effects of growth hormone and plays critical roles in growth, development, and metabolism. IGF-1 signals through the IGF-1 receptor (IGF-1R), a receptor tyrosine kinase that activates PI3K/Akt and MAPK/ERK pathways.
In circulation, most IGF-1 is bound to IGF-binding proteins (IGFBPs), which regulate its bioavailability, half-life, and tissue distribution. This binding significantly limits the amount of free, active IGF-1 available to stimulate receptors.
LR3 Modifications
IGF-1 LR3 incorporates two key modifications to native IGF-1:
- Arginine substitution at position 3 (R3): Glutamic acid is replaced with arginine
- N-terminal extension: A 13-amino acid extension is added to the N-terminus
- Combined effect: Dramatically reduced binding to IGFBPs
- Result: Enhanced bioavailability and 2-3x greater potency than native IGF-1
Pharmacokinetic Advantages
The reduced IGFBP binding of IGF-1 LR3 has profound pharmacokinetic consequences. While native IGF-1 has a half-life of only 10-20 minutes in free form, IGF-1 LR3 maintains activity for 20-30 hours due to its resistance to sequestration by binding proteins.
This extended activity allows for less frequent dosing in research protocols and provides more sustained receptor activation, which may be advantageous for studying long-term cellular responses.
Research Applications
Cell Culture
IGF-1 LR3 is widely used as a cell culture supplement to promote cell survival, proliferation, and differentiation. Its stability in culture media and potent activity make it more economical and effective than native IGF-1 for long-term cultures.
Muscle Biology
Research demonstrates that IGF-1 LR3 promotes myoblast proliferation, satellite cell activation, and myotube hypertrophy. Studies explore its effects on muscle protein synthesis, fiber type expression, and regeneration following injury.
Metabolic Studies
IGF-1R activation influences glucose metabolism, lipid handling, and whole-body energy balance. IGF-1 LR3 serves as a tool to study these metabolic effects, particularly in contexts where sustained receptor activation is relevant.
Tissue Engineering
The growth-promoting properties of IGF-1 LR3 make it valuable in tissue engineering applications. Research explores its use in promoting tissue development in scaffolds, organoid cultures, and regenerative medicine models.
Comparison with Other IGF-1 Forms
- Native IGF-1: Short half-life, fully regulated by IGFBPs, physiological reference
- IGF-1 DES: N-terminal tripeptide deletion, moderate IGFBP resistance
- IGF-1 LR3: Full length plus extension, greatest IGFBP resistance and potency
- Mecasermin: Recombinant human IGF-1 for reference studies
Note: IGF-1 LR3 is a research compound for laboratory studies only. Its potent growth factor activity requires careful experimental design and appropriate safety considerations.
Key Research References
- Francis GL, Ross M, Ballard FJ, et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology. 1992;8:213-223. doi:10.1677/jme.0.0080213
- Tomas FM, Knowles SE, Owens PC, et al. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I. Biochemical Journal. 1991;276:547-554. doi:10.1042/bj2760547
- Ballard FJ, Francis GL, Ross M, et al. Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding. Biochemical and Biophysical Research Communications. 1987;149:398-404. doi:10.1016/0006-291x(87)90380-x
- Tomas FM, Knowles SE, Owens PC, et al. Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. Journal of Endocrinology. 1992;135:193-206. doi:10.1677/joe.0.1350193
Related Articles
SS-31 (Elamipretide): Targeting Mitochondrial Dysfunction
Explore the mechanism and applications of SS-31, a cell-permeable peptide that selectively targets the inner mitochondrial membrane for advanced bioenergetics research.
9 min readRead
GHK-Cu Copper Peptide: Gene Expression and Tissue Remodeling
Understanding the multifaceted actions of GHK-Cu, from copper delivery and gene expression modulation to its roles in wound healing and tissue regeneration research.
11 min readRead
Research Use Only: The information in this article is for educational and research purposes only. All products mentioned are intended for laboratory research use only and are not approved for human or veterinary use.